Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes

Table 3

Risk factors for the composite efficacy outcomes of ACS patients with diabetes in multivariable analysis.

Variable	Multivariable OR (95% CI)	value	Multivariable OR (95% CI)	value
Age, years	1.04 (0.98–1.09)	0.186	1.03 (0.98–1.08)	0.267
History
Hypertension	2.14 (0.90–5.09)	0.085	1.85 (0.84–4.05)	0.125
Liver insufficiency	6.55 (1.73–24.78)	0.006	4.52 (1.74–11.77)	0.002
Biomedical indicator
Hemoglobin	0.99 (0.98–1.01)	0.184	0.99 (0.98–1.00)	0.181
eGFR	0.98 (0.97–1.00)	0.069	0.98 (0.97–1.00)	0.026
Grouping (ticagrelor vs. clopidogrel)	—	—	0.83 (0.44–1.56)	0.561

95% CI: 95% confidence interval; OR: odds ratio; : logistic regression analysis; : Cox survival analysis; BMI: body mass index; MI: myocardial infarction; GI: gastrointestinal; RAAS: renin-angiotensin-aldosterone system; ALT: alanine aminotransferase; eGFR: estimated glomerular filtration rate.